Navigation Links
Stopping Controversial Asthma Drugs Could Have Downside: Study
Date:8/27/2012

By Randy Dotinga
HealthDay Reporter

MONDAY, Aug. 27 (HealthDay News) -- It's OK for some patients with asthma to stick with a combination of medications instead of abandoning one because of concerns about complications, a new analysis of existing research suggests.

The U.S. Food and Drug Administration has warned that asthma patients who take both long-acting beta-agonist and inhaled corticosteroid medications should be cautious about using them together once their condition is under control.

Long-acting beta-agonists -- such as drugs known by the brand names Serevent, Foradil and Brovana -- could cause side effects, the FDA cautioned, as could combination drugs. For that reason, the agency suggested that patients consider going with inhaled corticosteroids alone.

However, the new analysis came to a different conclusion. "Adding a long-acting beta-agonist to an inhaled corticosteroid medication makes a lot of sense in a number of patients since you get better control of the disease," said Dr. Thomas Casale, chief of allergy and immunology at Creighton University, and lead author of the report.

The report was published online Aug. 27 in the journal Archives of Internal Medicine.

At issue is how to best treat adults and older children who suffer from moderate to severe asthma.

Inhaled corticosteroids, which come in inhalers and are known by brand names such as Azmacort and Flovent, are often prescribed by themselves to reduce wheezing and other symptoms. They're usually taken daily but don't relieve asthma attacks when they're occurring. (Short-acting beta-agonists, such as the drug albuterol, treat asthma attacks themselves.)

The newer long-acting beta-agonists are frequently used with inhaled corticosteroids. Some medications, sold under the brand names Symbicort and Advair, combine both types of drugs.

This latest analysis, which examined five studies involving patients ag
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Stopping Blood Thinners Raises Stroke Risk for Patients With Irregular Heartbeat
2. Stopping and starting cancer cell cycle weakens and defeats multiple myeloma
3. Opioid receptors as a drug target for stopping obesity
4. U.S. Gives Green Light to Publish Controversial Bird Flu Research
5. Controversial vaccine trial should never have been run in India, researchers say
6. Supreme Court Backs Much of Controversial Health Reform Law
7. Rapid Asthma Treatment in ER May Prevent Admission
8. Some Schools Dont Let Kids Carry Asthma Inhalers
9. Secondhand smoke continues to vex children with asthma
10. Many Asthmatic Kids Harmed by Secondhand Smoke: Study
11. Seniors Undertreated for Asthma, and Many Skip Inhalers: Study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Stopping Controversial Asthma Drugs Could Have Downside: Study
(Date:7/11/2014)... Volunteers from Scientology Churches and Missions are ... education lectures, forums and conferences, information stands, sports events, ... world. , Drug abuse is an international epidemic. According ... of alcohol and illicit drugs costs more than $425 ... and healthcare. , In the face of statistics ...
(Date:7/11/2014)... 11, 2014 The report, “Specialty ... Applications & Geography - 2018,” defines and segments ... with an analysis and forecast of the volumes ... fibers (Para aramids, meta aramids, UHMW Polyethylene, carbon ... PPS fiber, PBI fiber, PBO fiber, and liquid ...
(Date:7/11/2014)... 11, 2014 Utilizing the Keller Funnel, ... William Koenig, has topped a record number of complication-free ... performed over 400 successful procedures without the occurrence of ... well known across the country for his expertise with ... has long been the foundation for numerous studies and ...
(Date:7/11/2014)... 2014 (HealthDay News) -- Children who have emergency ... complications and potentially even death than those who ... However, the Johns Hopkins researchers noted that ... researchers analyzed data on nearly 440,000 simple emergency ... over a 22-year period. The surgeries are ...
(Date:7/11/2014)... The report “Probiotics Market by Products (Functional ... (Regular, Therapeutic, Preventive Health Care) & Ingredients (Lactobacilli, ... 2019 ” defines and segments the global probiotics ... market value of probiotic products and ingredients. The ... for the global market with an analysis of ...
Breaking Medicine News(10 mins):Health News:Scientologists Taking Action against Drug Abuse 2Health News:Scientologists Taking Action against Drug Abuse 3Health News:Specialty Synthetic Fibers & Glass Fiber Market Poised to Reach $20.1 Billion at a CAGR of 5.2% by 2018 – Report by MarketsandMarkets 2Health News:Specialty Synthetic Fibers & Glass Fiber Market Poised to Reach $20.1 Billion at a CAGR of 5.2% by 2018 – Report by MarketsandMarkets 3Health News:Specialty Synthetic Fibers & Glass Fiber Market Poised to Reach $20.1 Billion at a CAGR of 5.2% by 2018 – Report by MarketsandMarkets 4Health News:Rochester Surgeon Hits Milestone with Keller Funnel 2Health News:Emergency Surgeries on Weekends Riskier for Kids: Study 2Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 2Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 3Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 4Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 5
... experiences on anti-aging and ... personal beauty, ... public launch of the first consumer website dedicated,to consumer reviews and ... engage in an,open and honest conversation about important decisions that affect ...
... 11:00AM Adults with Attention Deficit Hyperactivity ... Extended-release Tablets showed significant improvements in ADHD symptom ... study results presented today at a major psychiatric ... adolescents with ADHD is clearly established but relatively ...
... Mid-Sized Companies Control Health Care Costs, DALLAS, ... Kenneth H. Cooper, M.D., M.P.H., Cooper Aerobics Enterprises,Inc., ... 37-year,history. Cooper Aerobics Enterprises purchased Health At Work, ... a new division, Cooper Benefits,LLC. Cooper Benefits ...
... have been found in related literature. One extremely rare ... of the World Journal of Gastroenterology because of its ... and sex factors, clinical and histopathological findings, diagnostic methods ... available literature. , The article reported one patient ...
... Ala. University of Alabama at Birmingham (UAB) researchers ... progression and switches on front-to-back body patterning in tadpoles. ... in understanding the complex DNA and cell interplay that ... and other diseases. , The UAB team focused on ...
... AMCS ),announces the following Webcast: (Logo: http://www.newscom.com/cgi-bin/prnh/20060202/AMICASLOGO ... 1, 2007 @ 8:30 AM ET, Where: http://www.videonewswire.com/event.asp?id=43463 ... on to the web at the address ... Inc, 617-779-7892. If you are unable to participate during the ...
Cached Medicine News:Health News:Consumers Open Up on RealSelf.com About 'Getting Work Done' 2Health News:Consumers Open Up on RealSelf.com About 'Getting Work Done' 3Health News:New study of Concerta showed significant improvement of ADHD symptom management in adults 2Health News:An Industry First: New Cooper Health Company Makes Group Employee Benefits Consulting and Wellness Program Design a Package Deal 2Health News:An Industry First: New Cooper Health Company Makes Group Employee Benefits Consulting and Wellness Program Design a Package Deal 3Health News:An Industry First: New Cooper Health Company Makes Group Employee Benefits Consulting and Wellness Program Design a Package Deal 4Health News:The largest colonic lipoma to date 2Health News:Cell pathway, disease linked to histone action 2
(Date:7/10/2014)... , July 10, 2014  The U.S. Department of ... grant to University Hospitals (UH) Case Medical Center Seidman ... national model aimed at improving care for patients with ... the project will test a unique model developed at ... late-stage disease, significant comorbidities, or demonstrated need for high ...
(Date:7/10/2014)... DIEGO , July 10, 2014  RESMED INC. (NYSE: ... its fourth quarter and fiscal year ended June 30, 2014 ... Stock Exchange market close. A press release with ResMed,s results ... the company will host a webcast to discuss operating results ... to begin at 1:30 p.m. US Pacific Time and the ...
(Date:7/10/2014)... LAVAL, Quebec , July 10, 2014  Valeant ... TSX: VRX) today announced it has completed the sale ... Sculptra, and Dysport owned or held by Valeant for ... agreement with Nestle S.A, which recently completed its acquisition ... complete the divestiture of our products to a company ...
Breaking Medicine Technology:University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 2University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 3University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 4ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2
... 2, 2011 ViroPharma Incorporated (Nasdaq: VPHM ) ... officer of ViroPharma, will present at the Jefferies 2011 Global ... 2011.  The conference is being held in New York City. ... through www.viropharma.com and available for a period of ...
... be presented in a poster at the 2011 Annual Meeting ... in Chicago, Illinois June 3-7 by researchers from The University ... that a laboratory test developed by Biocept, Inc. for the ... Disseminated Tumor Cells (DTCs) can provide potentially valuable information to ...
Cached Medicine Technology:MD Anderson and Biocept Scientists to Present Poster at ASCO on Disseminated Tumor Cells (DTCs) in Bone Marrow and Circulating Tumor Cells (CTCs) in Blood in Early Stage Breast Cancer Patients 2MD Anderson and Biocept Scientists to Present Poster at ASCO on Disseminated Tumor Cells (DTCs) in Bone Marrow and Circulating Tumor Cells (CTCs) in Blood in Early Stage Breast Cancer Patients 3
... polymerase chain reaction (PCR) to amplify and ... first to fully automate and integrate all ... sample preparation, DNA amplification and detection. Designed ... PCR test results from a raw sample ...
... For use as a non-reactive quality assurance reagent ... Toxoplasma gondii (TOXO IgG and TOXO IgM), IgG ... and rubella IgM), IgG and IgM antibodies to ... IgM antibodies to herpes simplex virus types 1 ...
... a fully automated system with,a disposable ... new refractive procedure known,as Epi-Lasik. The ... epithelium from the,Bowmans membrane leaving a ... the structural integrity,of the stroma and ...
... is a surgical/ mechanical device designed to ... the cornea above Bowman's layer. The Centurion ... used during LASEK to delaminate the epithelium. ... providing a 'minimal-touch' surgical approach, the SES ...
Medicine Products: